Juliet Moritz | Executive Director, Patient Engagement & Strategic Development
Premier Research

Juliet Moritz, Executive Director, Patient Engagement & Strategic Development, Premier Research

Executive Director, Strategic Development, Rare Diseases
Juliet Moritz has worked in clinical research for more than 25 years, and her extensive background covers the spectrum from single-site studies to large, multinational trials. She joined Premier Research in 2016 to specialize in rare diseases, supporting the strategic development of products that address unmet medical needs associated with rare and orphan afflictions.
Prior to joining Premier Research, Ms. Moritz was Associate Director of Global Project Management at PPD, overseeing infectious and respiratory disease research, and prior to that was Associate Director of Clinical Research at Knopp Biosciences. She held senior positions at Pfizer, Theravance, and Medifacts International and began her career as a clinical research associate.
Ms. Moritz holds a Master of Public Health degree from the Drexel University School of Public Health and a bachelor's degree in biology from the University of Pennsylvania. She is a member of the National Organization for Rare Disorders and the Drug Information Association.


Day 1 Orphan 14th Nov @ 17:00

Incorporating the Patient Voice into the Rare Disease Therapeutic Development Process

  • Significant attention has been given to the concept of patient engagement in the drug development process in the past few years and rightly so
  • This presentation will examine specific touchpoints during the rare disease therapeutic development process where the patient voice can be invaluable
  • Providing patients and their families, patient advocates, and sponsor companies an overview how and when the patient/caregiver perspective can shape drug development for a specific therapeutic

back to speakers